ArticleBMC medical informatics and decision making2021

The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study).

Juan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.